Me
Non vérifié

MedinCell

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueMédecine - DiversSanté
14/10/2026
Biotechnologie
Finance
Santé
Associations/Professionnels
Industrie pharmaceutique
Medincell Announces New Publication Date for Its Half-Year Financial Result (April 1st – September 30, 2026)
1.00
13/10/2026
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
Medincell Brings Total Non-Dilutive Financing Secured Since July 2026 to €41.8 Million with an Additional €13.8 Million Loan
1.00
09/10/2026
Web et Réseaux Sociaux
Industrie
Événements
Psychiatrie
Santé
Hygiène alimentaire
Médecine - Divers
Industrie pharmaceutique
Biotechnologie
Medincell Achieves Major Milestone with U.S. FDA Approval of WELTRUZA™ (olanzapine)
1.00
21/09/2026
Événements
Biotechnologie
Psychiatrie
Santé
Industrie pharmaceutique
Médecine - Divers
Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026
1.00
09/09/2026
Événements
Biotechnologie
Finance
Santé
Associations/Professionnels
Industrie pharmaceutique
Medincell to Participate in Upcoming Investor Conferences
1.00
01/09/2026
Marché du travail
Biotechnologie
Santé
Science
Industrie pharmaceutique
Medincell Appoints Edna Venneker, MD, as Chief Medical Officer
1.00
29/07/2026
Établissements Publics/Vente au Détail
Industrie
Biotechnologie
Industrie pharmaceutique
Santé
Psychiatrie
UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
1.00
28/07/2026
Marché du travail
Biotechnologie
Santé
Science
Industrie pharmaceutique
Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg
1.00
15/07/2026
Associations/Professionnels
Santé
Finance
Banque
Industrie pharmaceutique
Biotechnologie
Industrie
Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory
1.00
16/06/2026
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Marché financier
Medincell Reports FY 2025-26 Annual Results
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0